Get started
ORBUSN.MED.GRP.HL.DL-,001ORBUSN.MED.GRP.HL.DL-,001ORBUSN.MED.GRP.HL.DL-,001

ORBUSN.MED.GRP.HL.DL-,001

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

Q8T chart


Full chart

Q8T upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪355.06 M‬ EUR
Dividend yield (indicated)
2.76%
Price to earnings Ratio (TTM)
8.260
Basic EPS (TTM)
0.046 EUR
Net income (FY)
‪38.52 M‬ EUR
Revenue (FY)
‪159.16 M‬ EUR
Shares float
‪207.69 M‬
Beta (1Y)
0.60

Employees


Employees (FY)
‪1.33 K‬
Change (1Y)
+82 +6.57%
Revenue / Employee (1Y)
‪119.58 K‬ EUR
Net income / Employee (1Y)
‪28.94 K‬ EUR

About ORBUSNEICH MEDICAL GRP HLDGS LTD


Sector
Health Technology
Industry
Medical Specialties
CEO
David Chien
Headquarters
Hong Kong
FIGI
BBG01GN9DZ79
OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The firm through its subsidiaries engages in the manufacturing, trading, sales and marketing of medical devices & instruments used for the treatment of coronary and peripheral vascular diseases. The company was founded on July 22, 2021 and is headquartered in Hong Kong.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Q8T news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.


Frequently Asked Questions


The current price of Q8T is 0.394 EUR — it has increased by 7.07% in the past 24 hours. Watch ORBUSN.MED.GRP.HL.DL-,001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ORBUSN.MED.GRP.HL.DL-,001 stocks are traded under the ticker Q8T.
Q8T stock has risen by 6.49% compared to the previous week, the month change is a 14.53% rise, over the last year ORBUSN.MED.GRP.HL.DL-,001 has showed a −1.50% decrease.
We've gathered analysts' opinions on ORBUSN.MED.GRP.HL.DL-,001 future price: according to them, Q8T price has a max estimate of 0.76 EUR and a min estimate of 0.76 EUR. Watch Q8T chart and read a more detailed ORBUSN.MED.GRP.HL.DL-,001 stock forecast: see what analysts think of ORBUSN.MED.GRP.HL.DL-,001 and suggest that you do with its stocks.
Q8T reached its all-time high on May 17, 2023 with the price of 1.588 EUR, and its all-time low was 0.282 EUR and was reached on Aug 5, 2024. View more price dynamics on Q8T chart.
See other stocks reaching their highest and lowest prices.
Q8T stock is 6.60% volatile and has beta coefficient of 0.60. Track ORBUSN.MED.GRP.HL.DL-,001 stock price on the chart and check out the list of the most volatile stocks — is ORBUSN.MED.GRP.HL.DL-,001 there?
Yes, you can track ORBUSN.MED.GRP.HL.DL-,001 financials in yearly and quarterly reports right on TradingView.
ORBUSN.MED.GRP.HL.DL-,001 is going to release the next earnings report on Aug 15, 2025. Keep track of upcoming events with our Earnings Calendar.
Q8T net income for the last half-year is ‪20.22 M‬ EUR, while the previous report showed ‪17.60 M‬ EUR of net income which accounts for 14.91% change. Track more ORBUSN.MED.GRP.HL.DL-,001 financial stats to get the full picture.
Yes, Q8T dividends are paid annually. The last dividend per share was 0.01 EUR. As of today, Dividend Yield (TTM)% is 2.76%. Tracking ORBUSN.MED.GRP.HL.DL-,001 dividends might help you take more informed decisions.
ORBUSN.MED.GRP.HL.DL-,001 dividend yield was 2.67% in 2024, and payout ratio reached 26.65%. The year before the numbers were 1.42% and 23.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 12, 2025, the company has ‪1.33 K‬ employees. See our rating of the largest employees — is ORBUSN.MED.GRP.HL.DL-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORBUSN.MED.GRP.HL.DL-,001 EBITDA is ‪38.83 M‬ EUR, and current EBITDA margin is 24.18%. See more stats in ORBUSN.MED.GRP.HL.DL-,001 financial statements.
Like other stocks, Q8T shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORBUSN.MED.GRP.HL.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORBUSN.MED.GRP.HL.DL-,001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORBUSN.MED.GRP.HL.DL-,001 stock shows the neutral signal. See more of ORBUSN.MED.GRP.HL.DL-,001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.